by Clarevia Team | Oct 6, 2026 | Perspectives
Most drug candidates never make it all the way to patients. For early-stage healthcare investors, seeing a therapeutic advance from an early scientific idea through clinical development, acquisition, FDA approval, and ultimately toward commercialization is especially...